SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SNBR • US83125X1037

10.69 USD
-0.43 (-3.87%)
Last: Feb 10, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Overall SNBR gets a fundamental rating of 1 out of 10. We evaluated SNBR against 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of SNBR have multiple concerns. SNBR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year SNBR has reported negative net income.
  • In the past year SNBR has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.
  • SNBR had a positive operating cash flow in 4 of the past 5 years.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

  • SNBR has a Return On Assets of -10.42%. This is in the lower half of the industry: SNBR underperforms 73.33% of its industry peers.
  • SNBR has a Return On Invested Capital of 3.59%. This is comparable to the rest of the industry: SNBR outperforms 54.17% of its industry peers.
  • SNBR had an Average Return On Invested Capital over the past 3 years of 7.69%. This is below the industry average of 12.16%.
  • The last Return On Invested Capital (3.59%) for SNBR is well below the 3 year average (7.69%), which needs to be investigated, but indicates that SNBR had better years and this may not be a problem.
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROIC 3.59%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

  • SNBR has a Operating Margin (1.35%) which is in line with its industry peers.
  • SNBR's Operating Margin has declined in the last couple of years.
  • SNBR has a Gross Margin of 60.05%. This is amongst the best in the industry. SNBR outperforms 89.17% of its industry peers.
  • SNBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 60.05%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SNBR is destroying value.
  • SNBR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SNBR has less shares outstanding
  • Compared to 1 year ago, SNBR has a worse debt to assets ratio.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of -0.08, we must say that SNBR is in the distress zone and has some risk of bankruptcy.
  • SNBR has a Altman-Z score of -0.08. This is in the lower half of the industry: SNBR underperforms 77.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACC0.38
WACC9.43%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

  • A Current Ratio of 0.19 indicates that SNBR may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.19, SNBR is doing worse than 97.50% of the companies in the same industry.
  • A Quick Ratio of 0.09 indicates that SNBR may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.09, SNBR is doing worse than 95.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.09
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for SNBR have decreased strongly by -88.40% in the last year.
  • Looking at the last year, SNBR shows a very negative growth in Revenue. The Revenue has decreased by -16.95% in the last year.
  • The Revenue has been decreasing by -0.19% on average over the past years.
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%

3.2 Future

  • Based on estimates for the next years, SNBR will show a very strong growth in Earnings Per Share. The EPS will grow by 34.93% on average per year.
  • Based on estimates for the next years, SNBR will show a decrease in Revenue. The Revenue will decrease by -3.38% on average per year.
EPS Next Y-326.51%
EPS Next 2Y20.66%
EPS Next 3Y33.72%
EPS Next 5Y34.93%
Revenue Next Year-17.81%
Revenue Next 2Y-10.21%
Revenue Next 3Y-5.39%
Revenue Next 5Y-3.38%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SNBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

  • 95.83% of the companies in the same industry are more expensive than SNBR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.1
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SNBR's earnings are expected to grow with 33.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.66%
EPS Next 3Y33.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SNBR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SLEEP NUMBER CORP

NASDAQ:SNBR (2/10/2026, 8:00:02 PM)

10.69

-0.43 (-3.87%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners89.35%
Inst Owner Change1.97%
Ins Owners6.63%
Ins Owner Change4.57%
Market Cap243.63M
Revenue(TTM)1.44B
Net Income(TTM)-78.11M
Analysts48.89
Price Target9.18 (-14.13%)
Short Float %30.84%
Short Ratio7.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-915.82%
Min EPS beat(2)-937.57%
Max EPS beat(2)-894.07%
EPS beat(4)1
Avg EPS beat(4)-818.76%
Min EPS beat(4)-1452.29%
Max EPS beat(4)8.9%
EPS beat(8)3
Avg EPS beat(8)-410.77%
EPS beat(12)5
Avg EPS beat(12)-256.42%
EPS beat(16)7
Avg EPS beat(16)-175.27%
Revenue beat(2)0
Avg Revenue beat(2)-8.66%
Min Revenue beat(2)-10.05%
Max Revenue beat(2)-7.26%
Revenue beat(4)0
Avg Revenue beat(4)-6.41%
Min Revenue beat(4)-10.05%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.76%
Revenue beat(12)1
Avg Revenue beat(12)-4.74%
Revenue beat(16)3
Avg Revenue beat(16)-4.59%
PT rev (1m)63.64%
PT rev (3m)20%
EPS NQ rev (1m)-27.39%
EPS NQ rev (3m)-3433.33%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-307.58%
Revenue NQ rev (1m)-2.74%
Revenue NQ rev (3m)-2.74%
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-3.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 3.1
EPS(TTM)-3.41
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-2.06
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS63.22
BVpS-22.88
TBVpS-25.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROCE -13.07%
ROIC 3.59%
ROICexc 3.6%
ROICexgc 4.25%
OM 1.35%
PM (TTM) N/A
GM 60.05%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexgc growth 3Y-45.92%
ROICexgc growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score4
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.42
Cap/Depr 31.01%
Cap/Sales 1.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.09
Altman-Z -0.08
F-Score4
WACC9.43%
ROIC/WACC0.38
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
EPS Next Y-326.51%
EPS Next 2Y20.66%
EPS Next 3Y33.72%
EPS Next 5Y34.93%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%
Revenue Next Year-17.81%
Revenue Next 2Y-10.21%
Revenue Next 3Y-5.39%
Revenue Next 5Y-3.38%
EBIT growth 1Y-36.2%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year135.33%
EBIT Next 3Y53.85%
EBIT Next 5Y36.4%
FCF growth 1Y38.86%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-136.39%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%

SLEEP NUMBER CORP / SNBR FAQ

What is the fundamental rating for SNBR stock?

ChartMill assigns a fundamental rating of 1 / 10 to SNBR.


What is the valuation status of SLEEP NUMBER CORP (SNBR) stock?

ChartMill assigns a valuation rating of 2 / 10 to SLEEP NUMBER CORP (SNBR). This can be considered as Overvalued.


Can you provide the profitability details for SLEEP NUMBER CORP?

SLEEP NUMBER CORP (SNBR) has a profitability rating of 3 / 10.


What is the expected EPS growth for SLEEP NUMBER CORP (SNBR) stock?

The Earnings per Share (EPS) of SLEEP NUMBER CORP (SNBR) is expected to decline by -326.51% in the next year.